Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Ako

Showing results (501-510 of 547) with videos related to

Pageof 55
Sort By:
The American Journal of Cardiology|November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Cardiovascular Intervention and Therapeutics|October 10, 2020
Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature reviewTomonori Itoh, Takumi Kimura, Akihito Kudo, et al.
Nature Reviews. Cardiology|July 20, 2023
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosisDiana A Gorog, Jose Luis Ferreiro, Ingo Ahrens, et al.
JACC. Cardiovascular Interventions|June 24, 2017
Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent ImplantationMasato Nakamura, Raisuke Iijima, Junya Ako, et al.
Cardiovascular Intervention and Therapeutics|May 12, 2025
Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registryMasato Nakamura, Nehiro Kuriyama, Yutaka Tanaka, et al.
American Journal of Preventive Cardiology|July 30, 2021
Tackling cardiometabolic risk in the Asia Pacific regionJian-Jun Li, Khung Keong Yeo, Kathyrn Tan, et al.
Frontiers in Medicine|June 7, 2023
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trialTatsuhiko Wada, Makoto Hibino, Hiromi Aono, et al.
Cardiovascular Intervention and Therapeutics|November 13, 2020
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2Hirotoshi Watanabe, Takeshi Morimoto, Manabu Ogita, et al.
Journal of the American Heart Association|October 24, 2019
Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary SyndromesErika Yamamoto, Taishi Yonetsu, Tsunekazu Kakuta, et al.
International Heart Journal|February 21, 2018
A High Level of Blood Urea Nitrogen Is a Significant Predictor for In-hospital Mortality in Patients with Acute Myocardial InfarctionYu Horiuchi, Jiro Aoki, Kengo Tanabe, et al.
Pageof 55

Showing results (501-510 of 547) with videos related to

Sort By:
Pageof 55
The American Journal of Cardiology|November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Cardiovascular Intervention and Therapeutics|October 10, 2020
Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature reviewTomonori Itoh, Takumi Kimura, Akihito Kudo, et al.
Nature Reviews. Cardiology|July 20, 2023
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosisDiana A Gorog, Jose Luis Ferreiro, Ingo Ahrens, et al.
JACC. Cardiovascular Interventions|June 24, 2017
Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent ImplantationMasato Nakamura, Raisuke Iijima, Junya Ako, et al.
Cardiovascular Intervention and Therapeutics|May 12, 2025
Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registryMasato Nakamura, Nehiro Kuriyama, Yutaka Tanaka, et al.
American Journal of Preventive Cardiology|July 30, 2021
Tackling cardiometabolic risk in the Asia Pacific regionJian-Jun Li, Khung Keong Yeo, Kathyrn Tan, et al.
Frontiers in Medicine|June 7, 2023
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trialTatsuhiko Wada, Makoto Hibino, Hiromi Aono, et al.
Cardiovascular Intervention and Therapeutics|November 13, 2020
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2Hirotoshi Watanabe, Takeshi Morimoto, Manabu Ogita, et al.
Journal of the American Heart Association|October 24, 2019
Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary SyndromesErika Yamamoto, Taishi Yonetsu, Tsunekazu Kakuta, et al.
International Heart Journal|February 21, 2018
A High Level of Blood Urea Nitrogen Is a Significant Predictor for In-hospital Mortality in Patients with Acute Myocardial InfarctionYu Horiuchi, Jiro Aoki, Kengo Tanabe, et al.
Pageof 55